Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Markusic

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2023
Sweeten the deal: Glycopolymer-based engineering to modulate autoreactive T cell responsesDavid M Markusic, Moanaro Biswas
Molecular Therapy. Methods & Clinical Development|January 24, 2020
Immune Response Mechanisms against AAV Vectors in Animal ModelsAshley T Martino, David M Markusic
Blood|May 17, 2014
A David promoter with Goliath strengthDavid M Markusic, Roland W Herzog
Journal of Genetic Syndromes & Gene Therapy|April 9, 2013
Liver-Directed Adeno-Associated Viral Gene Therapy for HemophiliaDavid M Markusic, Roland W Herzog
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2019
AAV-Mediated Gene Delivery to the Liver: Overview of Current Technologies and MethodsBrett Palaschak, Roland W Herzog, David M Markusic
Plos One|April 9, 2010
Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in ratsDavid M Markusic, Dirk R de Waart, Jurgen Seppen
Cellular Immunology|March 27, 2018
Liver induced transgene tolerance with AAV vectorsGeoffrey D Keeler, David M Markusic, Brad E Hoffman
Cellular Immunology|November 8, 2022
Manipulating the microbiome to enhance oral tolerance in food allergyMiguel Gonzalez-Visiedo, Michael D Kulis, David M Markusic
Blood|December 19, 2018
Update on clinical gene therapy for hemophiliaGeorge Q Perrin, Roland W Herzog, David M Markusic
Molecular Therapy. Methods & Clinical Development|January 6, 2015
Development of Gene Transfer for Induction of Antigen-specific ToleranceBrandon K Sack, Roland W Herzog, Cox Terhorst, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2023
Sweeten the deal: Glycopolymer-based engineering to modulate autoreactive T cell responsesDavid M Markusic, Moanaro Biswas
Molecular Therapy. Methods & Clinical Development|January 24, 2020
Immune Response Mechanisms against AAV Vectors in Animal ModelsAshley T Martino, David M Markusic
Blood|May 17, 2014
A David promoter with Goliath strengthDavid M Markusic, Roland W Herzog
Journal of Genetic Syndromes & Gene Therapy|April 9, 2013
Liver-Directed Adeno-Associated Viral Gene Therapy for HemophiliaDavid M Markusic, Roland W Herzog
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2019
AAV-Mediated Gene Delivery to the Liver: Overview of Current Technologies and MethodsBrett Palaschak, Roland W Herzog, David M Markusic
Plos One|April 9, 2010
Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in ratsDavid M Markusic, Dirk R de Waart, Jurgen Seppen
Cellular Immunology|March 27, 2018
Liver induced transgene tolerance with AAV vectorsGeoffrey D Keeler, David M Markusic, Brad E Hoffman
Cellular Immunology|November 8, 2022
Manipulating the microbiome to enhance oral tolerance in food allergyMiguel Gonzalez-Visiedo, Michael D Kulis, David M Markusic
Blood|December 19, 2018
Update on clinical gene therapy for hemophiliaGeorge Q Perrin, Roland W Herzog, David M Markusic
Molecular Therapy. Methods & Clinical Development|January 6, 2015
Development of Gene Transfer for Induction of Antigen-specific ToleranceBrandon K Sack, Roland W Herzog, Cox Terhorst, et al.
Pageof 5